Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

12th Closed Virtual Expert Meeting of the Editorial Board

27th May and 3rd June 2020

How much do you have to reduce Lp(a) to achieve significant clinical benefit?

How much do you have to reduce Lp(a) to achieve significant clinical benefit?

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Henry Ginsberg 

read more »
Bempedoic acid: The new kid on the block

Bempedoic acid: The new kid on the block

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Christie Ballantyne 

read more »
Immunotherapies in homozygous FH: Alirocumab and evinacumab

Immunotherapies in homozygous FH: Alirocumab and evinacumab

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Robert Rosenson 

read more »
Remnant lipoproteins and impact of PCSK9 inhibition

Remnant lipoproteins and impact of PCSK9 inhibition

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Chris Packard 

read more »
Genome-wide polygenic risk scores: Insights from ODYSSEY OUTCOMES

Genome-wide polygenic risk scores: Insights from ODYSSEY OUTCOMES

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Dr Charles Paulding and Amy Damask 

read more »
Genetic risk scores: How much do they add?

Genetic risk scores: How much do they add?

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Anne Tybjaerg-Hansen 

read more »
Inclisiran: Update on efficacy, dosing regimen, safety and COVT trial

Inclisiran: Update on efficacy, dosing regimen, safety and COVT trial

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Frederick Raal 

read more »
Lp(a): Findings in ODYSSEY OUTCOMES

Lp(a): Findings in ODYSSEY OUTCOMES

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Gregory Schwartz 

read more »
What’s new in very high-risk patients?

What’s new in very high-risk patients?

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Francois Mach 

read more »
Do the new ESC/EAS guidelines change your clinical practice? Acute coronary syndromes

Do the new ESC/EAS guidelines change your clinical practice? Acute coronary syndromes

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Ulf Landmesser 

read more »
Lp(a): Risk factor or causal factor? A critical appraisal

Lp(a): Risk factor or causal factor? A critical appraisal

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Borge Nordestgaard 

read more »
ODYSSEY OUTCOMES and stroke events

ODYSSEY OUTCOMES and stroke events

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Wouter Jukema 

read more »
Treat ischaemic stroke to target

Treat ischaemic stroke to target

Reports from the 12th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Pierre Amarenco 

read more »